Roche Diagnostics Sweden company information, Employees & Contact Information

Reminder: Invitation to Roche’s 3rd Quarter Sales 2025 Presentation Roche

Changes to the Roche Enlarged Corporate Executive Committee GlobeNewswire

Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology Investing News Network

Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test PR Newswire

Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025 PR Newswire

Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years GlobeNewswire

Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub Investing News Network

Roche’s Annual Report 2024 Roche

Roche's first respiratory test powered by TAGS technology receives FDA clearance for SARS-CoV-2, Influenza A, Influenza B and RSV PR Newswire

Roche commences tender offer for all shares of 89bio, Inc. GlobeNewswire

Are we overlooking the true value of innovation? Roche

Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire

CHMP recommends EU approval of Roche’s subcutaneous GlobeNewswire

AI and machine learning: Revolutionising drug discovery and transforming patient care Roche

Positive phase III results show Roche’s giredestrant GlobeNewswire

Digital pathology: Sharpening the edge of disease detection Roche

African Genomics Program Roche

Advancing diabetes care: How predictive technology improves daily management Roche

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine) GlobeNewswire

Roche receives CE mark for Contivue, its Port Delivery GlobeNewswire

Roche receives FDA 510(k) clearance for the first blood test in the U.S. measuring Lp(a) in molar units PR Newswire

Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU GlobeNewswire

Roche presents new insights in Alzheimer’s disease research GlobeNewswire

Roche’s Susvimo maintains vision over five years with two GlobeNewswire

From misdiagnosed heart attack to patient advocacy superhero Roche

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides GlobeNewswire

Roche Diagnostics Achieves Vitamin D Total Test InkFreeNews.com

Roche to advance prasinezumab into Phase III development for early-stage Parkinson's disease GlobeNewswire

Early data suggest Roche’s NXT007 may have the potential to GlobeNewswire

Roche Elecsys sFlt-1/PlGF ratio for preeclampsia receives FDA 510(k) clearance, offering a fast and reliable way to predict the risk of developing severe preeclampsia PR Newswire

Roche’s fenebrutinib maintains near-complete suppression of GlobeNewswire

Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management Pharmaceutical Executive

Bridging the Gap: Accessing eye care in rural areas Roche

Roche’s Annual Report 2023 Roche

Roche Appoints Wafaa Mamilli as Chief Digital Technology Officer Pharmaceutical Executive

Our strategy Roche

About Roche Roche

Pharma solutions Roche

Roche's Annual Report 2022 Roche

Our History Roche

Privacy notice Roche

Partnering Roche

Sustainability Roche

Accessibility statement Roche

The imCORE Network: Experts collaborating to fight cancer Roche

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology GlobeNewswire

Media Library Roche

Innovation Roche

Solutions Roche

Media Roche

Drug safety at Roche Roche

Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA PR Newswire

Calculating the unimaginable Roche

The history - and future - of blood glucose monitoring Roche

Annual General Meeting Roche

9 things you may not know about cancer Roche

Pharma partnering in Asia Roche

Innovation process Roche

Bridging the innovation-regulation gap Roche

Animal Research Roche

Kadcyla (trastuzumab emtansine) Roche

Modeling the future Roche

Biotechnology: CrossMAb technology Roche

Fighting cervical cancer around the globe Roche

New era of antibiotics potentially in sight after more than 50 years Roche

If you can’t test, you can’t treat Roche

Legal Statement Roche

A future free from cervical cancer Roche

The promise of growing a human organ-on-a-chip Roche

World Economic Forum shines a light on Roche’s Digitization efforts Roche

Privacy notice for pharmacovigilance, medical information and product complaints Roche

Harnessing the power of AI Roche

Unlocking access to comprehensive cancer care in Dubai Roche

What makes you, you: Nadya’s story Roche

Bringing patient support to a rare disease Roche

Science and the City: Basel Roche

Growing healthcare capacity to improve access to healthcare Roche

Our business Roche

Live well, work well Roche

It takes the power of partnership Roche

Colorectal cancer Roche

Governance Roche

Roche to acquire Viewics, Inc. to provide data-driven lab business analytics and add further digital capabilities along the laboratory value chain Roche

Rare diseases are not rare Roche

Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo PR Newswire

Roche introduces the navify brand for its digital health solutions at HLTH 2022 PR Newswire

Roche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024 PR Newswire

Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023 Yahoo Finance

Results of a six-month study combining Roche’s Esbriet with nintedanib in patients with IPF presented at ERS Roche

Roche closes acquisition of LumiraDx’s Point of Care technology to expand access to diagnostic testing in primary care GlobeNewswire

Roche advances AI-driven cancer diagnostics by expanding its digital pathology open environment PR Newswire

Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports PR Newswire

Roche Diagnostics sets new milestone in the Middle East with ISO27001 Information Security certification PR Newswire

Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization PR Newswire

Roche is awarded IDC Best in Future of Intelligence award for implementing data mesh strategy at scale with Immuta PR Newswire

Roche enters into a definitive merger agreement to acquire GlobeNewswire

Roche introduces navify® Sample Tracking for labs to track patient test samples before even reaching lab premises PR Newswire

Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU PR Newswire

Roche receives FDA approval for cobas EZH2 Mutation Test as a companion diagnostic for patients with follicular lymphoma PR Newswire

Roche Diagnostics Announces Matthew Sause As Chief Executive Officer - North America PR Newswire